PETMEDIX
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.
PETMEDIX
Industry:
Biotechnology Health Care
Founded:
2017-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.petmedix.co.uk
Total Employee:
1+
Status:
Active
Total Funding:
37 M GBP
Technology used in webpage:
SPF Domain Not Resolving Euro Google Apps For Business Google Maps OVH Google DNS Google Domains Google Cloud DNS
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Feel
Feel is a pure nutritional supplements startup.
Healthwire
Healthwire is a health-tech startup.
Caraway Therapeutics
Rheostat Therapeutics is a bio therapeutics company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Parkwalk Advisors
Parkwalk Advisors investment in Series B - PetMedix
Kyoritsu Corporation
Kyoritsu Corporation investment in Series B - PetMedix
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series B - PetMedix
Tencent
Tencent investment in Series B - PetMedix
Digitalis Ventures
Digitalis Ventures investment in Series B - PetMedix
Parkwalk Advisors
Parkwalk Advisors investment in Series A - PetMedix
Digitalis Ventures
Digitalis Ventures investment in Series A - PetMedix
Companion Fund
Companion Fund investment in Series A - PetMedix
More informations about "PetMedix"
PetMedix - Crunchbase Company Profile & Funding
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. …See details»
Member profile: PetMedix | BIA
Https://petmedix.co.uk. Membership category Corporate. The Glenn Berge Building, Babraham Research campus, Cambridge, CB22 3FH, United Kingdom. PetMedix at a glance. Antibody …See details»
PetMedix joins Zoetis to bring the benefits of species-specific ...
Sep 25, 2023 That is the whole point of our company,” commented Dr. Tom Weaver, co-founder and CEO of PetMedix. “I couldn’t be prouder of the PetMedix team’s accomplishments. ...See details»
More animal magic as Zoetis acquires PetMedix in Cambridge
Sep 18, 2023 Dr Tom Weaver, co-founder and CEO of PetMedix, said: “Today marks a new milestone as PetMedix joins forces with Zoetis, the world’s leading animal health …See details»
PetMedix Company Profile 2024: Valuation, Investors, Acquisition ...
Cambridge Innovation Capital, Digitalis Ventures, Kyoritsu Seiyaku, Parkwalk Advisors, and Tencent Holdings have invested in PetMedix. Who are PetMedix’s competitors? Boehringer …See details»
PetMedix Company Profile | Management and Employees List
[email protected]: PetMedix Top Competitors. Company Employees Revenue Top technologies; Saint-Gobain. 24: $1.7 M: Immundnz. 10: $3.6 M: Reinnervate. 99: $19.2 M: …See details»
PetMedix and Zoetis partner to develop species-specific antibody ...
Sep 5, 2024 PetMedix and Zoetis partner to develop species-specific antibody therapies for pets. PetMedix, a leader in discovering species-specific therapeutic antibodies for pets, announced …See details»
Petmedix | VentureRadar
PetMedix is utilising tried and tested antibody technology to develop treatments for diseases in companion animals. Monoclonal antibodies are now a hugely important human drug class but …See details»
PETMEDIX LTD Company Profile | BABRAHAM, United Kingdom
Find company research, competitor information, contact details & financial data for PETMEDIX LTD of BABRAHAM. Get the latest business insights from Dun & Bradstreet.See details»
PetMedix raises $37M Series B - Cambridge Innovation Capital
Sep 8, 2021 While the initial focus will be the United States, the company has built an international organisation and financing syndicate to support efforts in European and Asian …See details»
More Cambridge-US activity as PetMedix is acquired by Zoetis
Sep 27, 2023 Dr Jolyon Martin, left, co-founder and head of business development, with Dr Tom Weaver, CEO and co-founder, right. Located on Babraham Research Campus, PetMedix will …See details»
Cambridge-based PetMedix bags £27M funding to revolutionise …
PetMedix is a UK-focused biotech company that was founded in 2018. It spun out from the lab of Prof Allan Bradley FRS and is based upon the PhD work of his student, now PetMedix co …See details»
PetMedix - closes $37m Series B round - Parkwalk Advisors
Sep 8, 2021 This financing round will propel PetMedix from an R&D-stage, UK-focused biotech company, into a clinical-stage international organisation. PetMedix’s internal discovery …See details»
PetMedix raises $37M Series B / Veterinary Industry News
4 days ago This financing round will propel PetMedix from an R&D-stage, UK-focused biotech company, into a clinical-stage international organisation. PetMedix’s internal discovery …See details»
PetMedix set to transform companion animal health with …
PetMedix is looking to close the current extension to the Series A funding by Autumn 2019 and is interested in hearing from potential investment partners and M&A. Contact Jolyon Martin, …See details»
Cambridge-based PetMedix bags £27M funding to revolutionise …
Sep 8, 2021 PetMedix has now raised a notable £27 million in its series B funding round to help expand its business internationally. ... PetMedix’s co-founder Jolyon Martin says, ” These …See details»
PetMedix | London Startups
PetMedix. PetMedix is a biomedical company specializing in the development of species-specific, therapeutic antibodies for pets. The company's focus lies in leveraging its skilled scientific …See details»
PetMedix Raises $37M in Series B Funding - FinSMEs
Sep 8, 2021 PetMedix, a Cambridge UK-based animal health company, raised $37M in Series B funding. ... now PetMedix co-founder, Jolyon Martin. ... PetMedix has built an international …See details»
PetMedix raises $37M Series B - Vetreport.net
Sep 8, 2021 This financing round will propel PetMedix from an R&D-stage, UK-focused biotech company, into a clinical-stage international organisation. PetMedix’s internal discovery …See details»
PetMedix raises $37M Series B | Companion Consultancy - News
Sep 8, 2021 PetMedix™ announces today the completion of an oversubscribed $37M (£27M) Series B financing round that will be used to advance its innovative pipeline through clinical …See details»